Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
BEND2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LINC01521 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NLRX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP39 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RHBG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RCHY1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00665 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHX30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSNK2A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COPS4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RACGAP1P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CALCB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GJB6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CASP12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFKB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGHM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRCP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on